** Toothpaste maker Colgate-Palmolive CL.N forecast annual sales below Wall Street expectations after missing quarterly sales estimates on Friday, hurt by weak demand in North America and Latin America for its household products
** Median PT of 24 brokerages covering CL is $100 - LSEG data
RESILIENCE AMID MARKET UNCERTAINTY
** Morgan Stanley ("overweight", PT: $104) expects CL to maintain steady organic sales growth driven by strategic reinvestments, with a positive long-term outlook despite short-term challenges
** J.P. Morgan ("overweight", PT: $97) sees CL achieving moderate growth and improving profitability in 2025, despite facing challenges from currency fluctuations and tariffs
** Morningstar (fairvalue: $84) sees CL to keep investing heavily in R&D and marketing to strengthen its brand, while using strategic price hikes and new product innovations to counter currency impacts
** Stifel ("hold", PT: $93) is cautious about co's near-term performance due to slowing volume growth and market share concerns, despite some expected improvements in gross margin
** Stifel adds that they anticipate more modest gross margin expansion in 2025 compared to 2024, with increased but slowing ad spending
(Reporting by Rashika Singh in Bengaluru)
((rashika.singh@thomsonreuters.com))
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。